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The HIV-2 viral accessory protein Vpx is related to, but distinct from the Vpr protein of HIV-1. Vpx is packaged into virions and as a
component of the viral preintegration complex (PIC) is required for efficient virus replication in non-dividing cells. We have previously reported
that the minimal transferable region of Vpx that contained karyophilic properties was aa 65 to 72. Analysis of Vpx sequences from various HIV-2/
SIV strains reveals that this region contains highly conserved amino acids, including two basic residues (K68, R70) and three tyrosines (Y66, Y69,
Y71). Here, we demonstrate that mutation of the basic or tyrosine residues abolishes PIC nuclear import in arrested cells as assessed by PCR
detection of viral integration. Examination of cell-free virus by Western blot indicated that all mutant proteins were incorporated into virions,
suggesting that the lack of replication in arrested cells was not due to a loss of Vpx in target cells. Together, these studies map critical residues of
the Vpx nuclear localization signal that are required for efficient infection of non-dividing cells.
D 2005 Elsevier Inc. All rights reserved.Keywords: HIV-2; Vpx; Preintegration complex; Nuclear localizationIntroduction
A hallmark and critical determinant of the pathogenesis of the
lentivirus subfamily of retroviruses is the ability to infect non-
dividing cells. After reverse transcription, targeting of the viral
DNA to the nucleus of cells is mediated by a large nucleoprotein
preintegration complex (PIC). This complex, which has been
difficult to characterize, is comprised of both cellular and viral
components. Likely, only a small number of the cellular proteins
associated with the PIC have been identified. Among those
identified, only a few, including barrier to auto integration factor
(BAF) and HMG Y(I), have been shown to be functionally
relevant (Chen and Engelman, 1998; Farnet and Bushman,
1997; Harris and Engelman, 2000; Hindmarsh et al., 1999; Li et
al., 2000; Lin and Engelman, 2003). The viral components
include the dsDNA, reverse transcriptase, matrix, nucleocapsid,
integrase, and Vpr (HIV-1) or Vpx (HIV-2/SIV) proteins0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.10.036
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E-mail address: lratner@im.wustl.edu (L. Ratner).(Bukrinsky et al., 1993; Farnet and Haseltine, 1991; Hansen
and Bushman, 1997; Karageorgos et al., 1993; Miller et al.,
1997). HIV-2 contains both the vpr and vpx genes, each with
discrete functions (Fletcher et al., 1996). While Vpx is
homologous to HIV-1 Vpr, is packaged into virions, and is a
component of the HIV-2 PIC, it lacks a nuclear export signal and
any cell-cycle arrest function (Belshan and Ratner, 2003;
Hansen and Bushman, 1997). Therefore, like HIV-1 Vpr, Vpx
is necessary for effective nuclear translocation of the PIC, but is
dispensable for integration. Furthermore, SIVsm Vpx has been
demonstrated to be required for efficient virus dissemination and
pathogenesis in vivo (Hirsch et al., 1998).
In addition to its composition, the transport of the PIC remains
one of the least well understood aspects of HIV replication. Work
by McDonald et al. suggests that the PIC associates with and
traverses the microtubule network to microtubule organizing
centers near the nuclear envelope (McDonald et al., 2002).
However, it remains unclear what facilitates PIC transport along
the network. Furthermore, once the PIC reaches the nuclear
membrane, the sequence of events that result in the nuclear6) 118 – 126
www.e
Fig. 1. Conservation of the Vpx NLS and mutants constructed for these studies.
(A) Alignment of selected sequences from the Los Alamos HIV sequence
database. The consensus sequence is given at the top. Capital letters indicate
highly conserved amino acid residues, small-case letters denote dominant
amino acid residues, Fx_ indicates no dominant residue. (B) Summary of the
mutations constructed for the studies presented. RMX-D represents a clone in
which both methionine codons of vpx have been altered to abolish protein
translation.
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components of the HIV-1 PIC contain one or more karyophilic
signals including matrix, integrase, vDNA (central polypurine
tract), and Vpr (or Vpx for HIV-2/SIV) (reviewed in Goff, 2001;
Sherman and Greene, 2002; Stevenson, 1996). However,
deletion of any single signal results in only a modest reduction
of PIC import efficiency. Therefore, these signals do not appear
to be synergistic, but rather redundant.
HIV-2 Vpx is a small hydrophobic protein that is a
component of the PIC and required for efficient infection of
non-dividing cells (Mahalingam et al., 2001; Pancio et al., 2000;
Ueno et al., 2003). The localization of Vpx is context dependent.
Vpx has a nuclear localization signal (NLS), but no NES
(Belshan and Ratner, 2003). In the presence of unprocessed Gag
in a virus producing cell, Vpx is packaged into virions through
an interaction with the p6 region of Gag (Jin et al., 2001; Pancio
and Ratner, 1998; Selig et al., 1999). Packaging of Vpx is
necessary for its activity during the early stage of virus
replication. Expressed in the absence of the Gag polyprotein,
Vpx predominantly localizes to the nuclei of cells (Belshan and
Ratner, 2003; Mahalingam et al., 2001; Pancio et al., 2000). We
have mapped a minimal transferable nuclear localization signal
(NLS) to amino acids 65–72 (Belshan and Ratner, 2003);
however, other C-terminal residues have been implicated in
regulating Vpx nuclear localization and PIC import in non-
dividing cells (Belshan and Ratner, 2003; Pancio et al., 2000;
Rajendra Kumar et al., 2003). In these studies, there exists a
strong correlation between the ability of Vpx mutants to localize
to the nucleus and the ability of viruses containing those
mutations to infect non-dividing cells. Thus, Vpx appears to be a
critical regulator of HIV-2/SIV PIC nuclear import.
The goal of our ongoing studies is to characterize the
pathway of Vpx nuclear import as a means to dissect the
process of PIC transport and nuclear targeting. We have
examined the minimal transferable nuclear localization signal
of HIV-2 Vpx (. . .65SYTKYRYL72. . .). This stretch of amino
acids is highly conserved among HIV-2/SIV strains (Fig. 1A),
further suggestive evidence of the importance of this region.
Here, we use mutational analysis to study the Vpx NLS and
characterize the role of Vpx in PIC nuclear transport. We define
three critical residues (K68, Y69, R70) in the minimal
transferable NLS required for HIV-2 infection of non-dividing
cells. Mutation of any of these residues did not appear to inhibit
Vpx incorporation into virions, suggesting that the NLS is
separable from the packaging domain of Vpx. Nor did these
mutations impede HIV-2 infection of dividing cells. Thus, we
have defined several critical cis-acting residues of the Vpx
NLS for targeting of the HIV-2 PIC in non-dividing cells.
Results
Mutagenesis of conserved amino acids in the Vpx nuclear
localization signal (NLS)
Our previous studies identified two transferable NLSs of
Vpx that overlapped at amino acids 65–72 (Belshan and
Ratner, 2003). Our next goal was to identify the criticalresidues of Vpx to further characterize the pathway of Vpx
nuclear import and the role of Vpx in preintegration complex
(PIC) nuclear targeting. Examination of various HIV-2 and SIV
Vpx sequences in the Los Alamos Database indicated that
several amino acids within this region are highly conserved
among the HIV-2/SIV family (Fig. 1A), suggesting they are
essential for the function of the protein. In our previous study,
we noted that alanine substitution of both basic residues (K68
and R70) and/or the three tyrosine residues (Y66, Y69, Y71),
but not the serine residues ablated the nuclear localization of a
green fluorescent protein-Vpx fusion protein (Belshan and
Ratner, 2003). In the present studies, we wished to determine
the effect of these substitutions in Vpx on PIC import.
Therefore, we constructed a series of full length HIV-2
ROD10 molecular clones containing these original alanine
substitutions in Vpx and also constructed additional Vpx
mutants with different combinations of alanine substitutions for
the tyrosine residues (Fig. 1B).
Infection of MAGI-5 cells with viruses containing alanine
substitutions in the Vpx NLS
It has been known for some time that Vpx is dispensable for
replication in dividing cells in vitro (Hu et al., 1989; Kappes et
al., 1991; Marcon et al., 1991; Shibata et al., 1990; Yu et al.,
1991). To confirm that the molecular clones we constructed
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MAGI-5 indicator cells. Viruses were produced by transfection
of 293T cells, concentrated, and quantified by p27 ELISA.
MAGI-5 cells were infected in 96-well plates with equal
amounts of virus (usually 5 ng/well) for 48 h, then fixed and
stained for h-galactosidase expression. The virus titer was
calculated by the number of blue nuclei. As expected, all
viruses, including the vpx-deleted virus (RMX-delta) retained
the ability to infect dividing cells (Fig. 2). With the exception
of the triple tyrosine to alanine mutant (RMX-Y-A), all the
viruses infected the cells at levels similar to the wild-type
ROD10. RMX-Y-A consistently displayed approximately 70%
of the level of infection of the wild-type ROD10.
Amino acids 68–70 of Vpx are critical for HIV-2 infection of
non-dividing cells
Our previous studies demonstrated that mutation of the
basic and tyrosine residues disrupted the ability of GFP-Vpx to
localize to the nucleus of cells (Belshan and Ratner, 2003).
Next, we wanted to determine the effects of these substitutions
on the ability of HIV-2 to infect non-dividing cells. Given the
large number of mutants we needed to assay, we developed a
short-term arrested-cell assay rather than utilize the traditional
Mf infection assays. Adapted from the method described by
Brussel and Sonigo (2003), this assay detects integrated viral
DNA by nested PCR (see Materials and methods). For each
experiment, U937 cells were synchronized by serum starvation
for 48 h and half of the cells arrested by release into complete
medium containing 400 AM l-mimosine. The other half was
released into complete medium as a dividing cell control.
Growth-arrest of the cells was monitored by propidium iodine
staining at the end of the experiment (data not shown).Fig. 2. Infection of MAGI-5 cells by viruses containing mutations in Vpx.
MAGI-5 cells were infected and virus titer determined as described in Materials
and methods. Results are presented as a comparison to the wild-type ROD10
virus and represent at least three independent experiments with at least triplicate
infections. Bars denote standard error of the mean.Genomic DNA was isolated at 0, 24, and 48 h post-infection
to assess viral DNA integration by nested PCR. The first PCR
uses two Alu element primers and an HIV-2 LTR-specific
primer with a linker. This PCR amplifies LTR-genome
fragments of various sizes. The second PCR uses the linker
primer with another HIV-2 LTR primer and amplifies a specific
product of 242 bp. The second PCR was performed with
[32P]TTP for visualization of the product by autoradiography
after electrophoresis. Genomic DNA from a known number of
CEMx174 cells chronically infected with HIV-2ST (Kong et al.,
1988) was used as a positive control in each experiment (data
not shown). Each mutant virus was assayed at least three times
and the results presented in Fig. 3 represent the dominant
phenotype observed for each viral mutant.
Each individual experiment contained both ROD10 and the
vpx-deleted virus, RMX-D. As indicated, ROD10 infected the
arrested U937 cells only slightly less well than the dividing cells
(Fig. 3). RMX-D repeatedly failed to efficiently infect the
arrested U937 cells, but still infected the dividing cells.
Therefore, RMX-D acted as a negative control in each
experiment. Additional controls assayed but not shown included
uninfected cells and cells infected with heat-inactivated (65 -C
for 30min) ROD10. Integrated virus was not detected in either of
these cells after repeat experiments. Alanine substitution of
serine residues 65 and 67 (RMX-S-A) appeared to have no effect
on the ability of the virus to infect non-dividing cells. However,
alanine substitution of the three tyrosine residues at positions 66,
69, and 71 (RMX-Y-A) or both basic residues (K68, R70-RMX-
KR) abolished infection of the growth-arrested cells. Interest-
ingly, these results correlate well with the cell localization
phenotypes we previously observed with mutations in GFP-Vpx
(Belshan and Ratner, 2003).
The conservation and critical requirement of these tyrosine
residues for nuclear localization made it tempting to speculate
that phosphorylation of these residues could regulate Vpx
function. Although initial studies reported that HIV-2 Vpx was
not phosphorylated (Franchini et al., 1988), a recent study
demonstrated phosphorylation of SIV Vpx (Rajendra Kumar et
al., 2004). However, our own analysis by [32P]phosphoric acid
labeling of either virus or over-expressed Vpx failed to detect
any phosphorylation (data not shown). Furthermore, to assay
whether any such modification to the tyrosine residues was
important for PIC import, we constructed a clone in which we
substituted phenylalanine at the three tyrosine positions (RMX-
Y-F). This virus retained the ability to infect non-dividing cells
(Fig. 3). These two pieces of evidence suggest that phosphor-
ylation at these tyrosine residues does not regulate HIV-2 Vpx
function. Further mutation of the tyrosine residues indicated
that Tyr69 alone is critical for the ability of Vpx to mediate
infection of non-dividing cells. This is demonstrated by the fact
that any clone containing the Y69A substitution (RMX-
66,69A, RMX-69,71A, RMX-69A) was unable to efficiently
infect growth-arrested cells. Together, the results from this
series of experiments indicate that amino acids 68–70 of HIV-2
Vpx are critical for the infection of non-dividing cells.
We also determined the cell localization phenotype of GFP-
Vpx fusion proteins containing the tyrosine to alanine
Fig. 3. Ability of vpx-NLS mutant viruses to infect arrested and dividing U937 cells. U937 cells were growth arrested and infected as described in Materials and
methods. Cells were infected with viruses containing the indicated mutations in vpx. At the times noted, genomic DNA was harvested and the integration of viral
DNA detected by the nested PCR method described in the Materials and methods. Each mutant was assayed at least three times and the panel presented for each
mutant represents the dominant phenotype. Control PCR assays for the detection of h-globin indicated similar levels of genomic DNA (T10%) were isolated among
the samples (data not shown).
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observed, the fusion proteins containing the three tyrosine to
alanine substitutions (GFP-X-Y-A) or the Y69A mutation alone
(GFP-X-Y69A) displayed a loss of nuclear accumulation
compared to the wild-type GFP-Vpx fusion protein (GFP-X)
(Fig. 4). The other constructs containing the Y69A substitution
(Y66,69A and Y69,71A) also lost nuclear accumulation (data
not shown). Collectively, these and our previous localization
results (Belshan and Ratner, 2003) demonstrate that aminoFig. 4. Alanine substitution of Tyrosine 69 in the Vpx NLS abolishes nuclear accum
GFP-Vpx fusion protein constructs. 24 h later, the cells were fixed, permeabilized, sacids 68–70 are critical for nuclear localization of Vpx in
addition to the ability of HIV-2 to infect non-dividing cells.
The inability of Vpx NLS mutants to infect non-dividing cells
does not result from a loss of virion associated protein
Vpx is dispensable for replication in dividing, but not non-
dividing cells. To confirm that the defective phenotypes
observed in the non-dividing cell infection assay did not resultulation of GFP-Vpx. HeLa cells were transiently transfected with the indicated
tained with DAPI (lower panels), and imaged with a fluorescence microscope.
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examined whether the mutant viruses observed to be incompe-
tent to infect non-dividing cells incorporated the mutant Vpx
proteins into virions. Virus was produced by transient transfec-
tion of 293T cells. 48 h post-transfection, both the supernatants
and cell lysates were harvested. Virus in the supernatants was
concentrated by ultracentrifugation through a 20% sucrose
cushion (w/v in PBS). Vpx and p27 were detected on separate
blots using monoclonal antibodies (Fig. 5). Vpx was detected in
all the mutants except for the vpx-deleted mutant, RMX-D,
indicating that none of the substitutions were deleterious for Vpx
incorporation into virions. The results were not surprising as
previous studies indicate that the determinants of HIV-2 Vpx
packaging map to amino acids 74–86 (Jin et al., 2001). These
results indicate that the failure of the viruses containing the basic
or tyrosine mutations to infect non-dividing cells is not due to an
absence of Vpx in the incoming virus particles.
Discussion
HIV-2 Vpx is thought to have arisen as a gene duplication of
Vpr, and similar to HIV-1 Vpr Vpx is required for efficient PIC
nuclear import of non-dividing cells (Fletcher et al., 1996; Sharp
et al., 1996; Tristem et al., 1990, 1998). Indeed, Vpx and Vpr
sequences comprise a Protein Family (Pfam) domain (PF00522)
in their central regions (aa 5–99) (Bateman et al., 2004),
suggesting likely structural and functional conservation among
these proteins. Therefore, it has been proposed that Vpx uses a
method of nuclear import similar to Vpr. Since Vpr has been
shown to interact with importin a (Kamata et al., 2005; Popov et
al., 1998b; Vodicka et al., 1998) and other nucleoporins (Popov
et al., 1998a; Vodicka et al., 1998), it is likely that Vpr enters the
nucleus via the nuclear pore. Because of their similarities, weFig. 5. Incorporation of mutant Vpx proteins into virions. Virus was produced
by transient transfection of 293T cells and virus collected for 48 h. After the
final collection, the cell lysates were harvested, then the supernatants precleared
and the virus concentrated by ultracentrifugation through a 20% sucrose
cushion. Proteins were separated by SDS-PAGE and Vpx and the p27 capsid
proteins detected using specific antibodies as indicated.initially hypothesized that Vpx likely utilizes a similar method of
nuclear entry as Vpr. While still a viable hypothesis, several
findings suggest that Vpr may not be a model system for Vpx.
We have identified amino acids 65–72 as a minimal NLS of
HIV-2 Vpx, and a larger domain was confirmed to contain an
NLS by Kumar et al. (Belshan and Ratner, 2003; Rajendra
Kumar et al., 2003). Further confirmation of the role of this Vpx
domain in nuclear import would involve studies of the effect of
mutations described here on HIV-2 replication in macrophages.
However, the parental virus used in this study, ROD-10,
replicates inefficiently in macrophages (data not shown). Thus,
transfer of these mutations to a different HIV-2/SIV proviral
clone will be required for these future studies.
There are two points of interest concerning this region of
Vpx. First, this region is not homologous to the Vpr NLS and
lacks any recognizable classical NLS. Second, although this
region is highly conserved among numerous HIV-2/SIV isolates
and Vpx and Vpr constitute a Pfam, a predicted structural
alignment of Vpx with HIV-1 Vpr the region of Vpx containing
the NLS (aa 65–72) shows weak conservation relative to the
highly conserved core domain spanning aa 23–87. The smaller
region is predicted to loop out relative to the three helix structure
in Vpr (Fig. 6). Together, this demonstrates the significance of
the NLS region of Vpx, but suggests that the function(s)
associated with this region is distinct from Vpr. Furthermore,
several homology queries of this region with internet databases
yielded no matches. These data support the possibility that Vpx
utilizes a unique method of nuclear import, dissimilar to that of
Vpr. Indeed, we have performed several yeast two-hybrid
screens with Vpx in attempt to identify the pathway Vpx
interacts with to access the nucleus. In addition, we also assayed
Vpx with a battery of nuclear pore proteins and importins using
the yeast system. While our attempts have yielded no positive
interactions (data not shown), they highlight the differences
between HIV-1 Vpr and Vpx and suggest a novel method of
nuclear transport for Vpx.
Numerous mutations in the Vpx C-terminus have been
identified that disrupt infection of non-dividing cells. A loss of
Vpx function in PIC nuclear targeting may result from several
factors, including, but not limited to either a block of Vpx
incorporation into virions, a disruption of PIC nuclear import,
abolishment of Vpx association with the PIC, or a loss of
interaction with an unknown cellular factor required for PIC
import. Interestingly, to date, all of the mutations in Vpx that
disrupt PIC nuclear import or infection of non-dividing cells
have been shown to be nuclear localization defective. This
strong correlation suggests that the critical function of Vpx in
PIC nuclear transport is nuclear localization. However, there still
remains the question of the importance of other residues in the C-
terminus of Vpx. Amino acids identified as critical for Vpx
nuclear import and HIV-2/SIV infection of non-dividing cells
include residues within and without the characterized NLS, such
as aa 74–80, H82, G86, C87, and the proline-rich region (101–
109) (Belshan and Ratner, 2003; Mahalingam et al., 2001;
Pancio et al., 2000). Any of these mutations may deleteriously
affect Vpx structure, Vpx association with the PIC, or the
interaction of Vpx with a yet-to-be identified cellular factor.
Fig. 6. Prediction of helical structure in Vpx. Amino acids 23–87 of Vpx were
modeled against the HIV-1 Vpr structure (Morellet et al., 2003) using Robetta/
Rosetta (Kim et al., 2004; Chivian et al., 2003; Rohl et al., 2004). Helix 1–3
indicates predicted a-helices at aa 24–37, 42–59, and 72–86, respectively. The
predicted region containing the NLS, aa 60–71, is in orange between helix 2
and 3. The figure was rendered with DeepView (Guex and Peitsch, 1997).
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have been examined for their ability to associate with the PIC.
Further structure/function studies must be undertaken to
delineate the role of these residues in PIC nuclear transport.
We observed one result that directly contrasts another report
indicating that triple tyrosine to alanine mutation in SIV Vpx
ablates virion incorporation but has no effect on nuclear
localization of Vpx (Mahalingam et al., 2001). It is presently
unclear to us why we observe a contradictory phenotype, but this
may be the result of disparate methods or differences between
HIV-2 and SIV packaging of Vpx. Further studies are required to
delineate the observed differences.
The Vpr/Vpx proteins are considered an important compo-
nent of the karyophilic signal of the HIV preintegration complex
(PIC). The current data suggest that loss of HIV-2/SIV Vpx is
more deleterious than the loss of HIV-1 Vpr (Connor et al., 1995;
Haffar et al., 2000; Heinzinger et al., 1994; Mahalingam et al.,
2001; Pancio et al., 2000; Ueno et al., 2003; Yu et al., 1991);
however, additional and more sensitive assays with HIV-2/SIV
need to be performed to bolster this conclusion. Similarly, it has
been demonstrated in vivo that deletion of Vpx reduces virus
dissemination and productive infection in pigtailed macaques
(Hirsch et al., 1998). Combination of the in vitro and in vivo data
supports the idea that Vpx is a critical karyophilic component of
the HIV-2/SIV PIC. However, it should be noted that neither
integrase andMANLSmutants, nor cPPTmutants have yet to be
assessed for SIV in vivo. Such studies would likely clarify the in
vivo contribution of each putative karyophilic signal and further
our understanding of PIC nuclear targeting.
Materials and methods
Molecular clone construction and virus production and
analysis
ROD10 was a kind gift of Klaus Strebel (Bour et al., 1996).
Mutagenesis of vpx was performed using a shuttling vectorcontaining a modified SacI–SacI fragment (nt 5284–5876) of
ROD10 in pGEM-T (Promega, Madison, WI). The modification
removed the naturally occurring SacI restriction site at nt 5700.
This was accomplished by PCRoverlap extensionmutagenesis and
did not alter the vpr ORF. The final plasmid (pX-CC) was used to
construct the series of mutations in vpx by overlap extension PCR.
Mutagenesis was confirmed by sequencing and then the fragment
was digested and ligated into the parental pROD10. The final
clones were also confirmed by sequencing. The sequences of all
primers were designed from the Genbank sequence of ROD10
(accession # X05291). The sequence of these oligos and those
used for the mutagenesis are available upon request.
Virus stocks were produced by transient transfection of
293T cells. 1  106 293T cells were seeded in 10 cm2 plates. 24
h later, the media were changed and the cells were transfected
with 20 Ag of the plasmid molecular clone using TransIT-LT1
as described by the manufacturer (Mirus Bio, Madison, WI).
Every 24 h the media were harvested and replaced with fresh
media. After 72 h, the virus-containing media were clarified
and then concentrated by ultracentrifugation (26,000 rpm for
90 min in a Beckman SW28.1 rotor) through a 20% sucrose
cushion. After centrifugation, the media and sucrose were
removed and the pelleted virus resuspended in OptiMEM
(Invitrogen, Carlsbad, CA), aliquoted, and stored at 80 -C.
Virus was quantified by p27 ELISA as described by the
manufacturer (Beckman-Coulter, Miami, FL).
Detection of Vpx in virions
Viruses were produced in the manner described above for
analysis of Vpx incorporation. However, after the 48 h harvest,
the virus was clarified and pelleted through 20% sucrose. At
this time, the cells were also harvested, washed, and lysed with
0.5 mL M-PER solution (Pierce Biotechnology, Rockford, IL).
Protein concentrations of the cell lysates were determined by
BCA protein assay as described by the manufacturer (Pierce
Biotechnology). The pelleted virus was resuspended directly
into 0.25 mL 1 SDS-PAGE sample buffer. Vpx and p27
capsid were detected by SDS-PAGE and Western blotting as
follows: Either 20 AL of pelleted virus or 20 Ag of cellular
protein per lane was separated by SDS-PAGE, then blotted to
PVDF. Western blots for Vpx were performed using a
monoclonal anti-Vpx antibody (Kappes et al., 1993) followed
by an HRP-conjugated anti-mouse secondary antibody (Amer-
sham Biosciences, Piscataway, NJ) and was detected using the
ECL Plus system as described by the manufacturer (Amersham
Biosciences). The p27 capsid protein was detected using the
AG3.0 anti-p24 monoclonal antibody (Simm et al., 1995) and
an HRP-conjugated anti-mouse secondary antibody.
GFP fusion protein localization
GFP-Vpx is described elsewhere (Pancio et al., 2000).
Mutations were introduced into GFP-Vpx by PCR overlap
extension and confirmed by sequencing. HeLa cells were
maintained and transfected similar to 293T cells as described
above. The transfection, fixation, DAPI staining, and imaging of
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Ratner, 2003). Images presented represent the dominant
phenotype observed.
Virus infections
The MAGI-5 indicator cell line has been described
elsewhere (Pirounaki et al., 2000). The cells were maintained
in DMEM supplemented with 10% fetal calf serum, 4 mM l-
glutamine, 1 mM Na-pyruvate, and 100 Ag/mL penicillin/
streptomycin. To assay virus infection, MAGI-5 cells were
seeded at 0.4  104 cells/well in a 96-well plate. The next day,
the cells were infected in triplicate with 1, 5, and 25 ng of virus
in the presence of 20 Ag/mL of DEAE-dextran. Forty-eight
hours later, the cells were fixed and stained for the expression
of h-galactosidase. The number of blue nuclei was counted to
determine the level of infection. Results are presented as a
percentage of the level of infection of the parental ROD10 and
represent a total of at least three independent experiments
(therefore 9+ wells for each virus).
U937 cells were maintained in RPMI supplemented with
15% fetal calf serum, 4 mM l-glutamine, and 100 Ag/mL
penicillin/streptomycin. For the experiments examining the
infection of arrested cells, 48 h prior to infection, the cells were
pelleted, washed, and resuspended in serum-free RPMI (still
containing l-glutamine and antibiotics) to arrest and synchro-
nize the cells. Immediately prior to infection, the cells were
counted and resuspended at 1  106 cells/mL in either
complete RPMI (dividing) or complete RPMI containing 4
AM l-mimosine to arrest cells. 4 mL of cells (4  106) was
aliquoted into one well of a 6 well plate for each virus, plus one
additional well of dividing and non-dividing cells for cell-cycle
analysis after the infections were completed. Cells were then
infected with 20 Ag of virus that had been treated with Turbo
DNaseI (Ambion, Austin, TX) for 30 min at 37 -C. At 0, 24,
and 48 h post-infection, 1 mL of cells (¨1  106 cells) was
removed. Cells were pelleted, the media removed, and the cells
washed, and resuspended in 0.2 mL PBS. RNA-free, genomic
DNA was isolated using the DNeasy method as described by
the manufacturer, Qiagen (Valencia, CA). After the final time
point, cell-cycle analysis was performed to confirm that the
cells treated with l-mimosine were arrested using the
CycleTEST PLUS DNA Reagent kit as described by the
manufacturer (Becton Dickinson, San Jose, CA).
Nested Alu PCR
Detection of integrated proviral DNAwas performed using a
nested PCR method adapted from Brussel and Sonigo (2003).
The initial PCR used 500 nM of HIV-2 LTR specific primer with
a linker (underlined) and two Alu repeat element primers to
amplify a pool of products from the genomic DNA. The HIV-2
primer (LROD13) sequence was 5V-ATGCCACGTAAGC-
GAAACTGCGAGGCTGGCAGATTGAGCCCTG-3V. The
first Alu primer was 5V-TCCCAGCTACTGGGGAGGCT-
GAGG-3V; the second was 5V-GCCTCCCAAAGTGCTGGGA-
TTACAG-3V. A 20 AL volume PCR reaction was performedusing a 1 JumpStart REDTaq reaction (Sigma, St. Louis, MO)
with 4 AL of the genomic DNA sample as a template. After an
initial 8 min 95 -C incubation to activate the enzyme, 12 cycles
of 95 -C for 30 s, 60 -C for 30 s, and 72 -C for 3 min were
performed. The second PCR was performed with 2 AL of the
initial PCR using a 1 JumpStart REDTaq reaction supple-
mented with 0.1 ACi [32P]a-TTP per 20 AL reaction. For this
reaction, 500 nM of the linker primer (5V-ATGCCACGTAAGC-
GAAACTGC-3V) and an HIV-2 U5-specific primer (5V-TTACT-
CAGGTGAACACCGAATGACCAGGC-3V) were used. After
an initial 8 min 95 -C incubation to activate the enzyme, the
reaction conditions for the second PCR were 35 cycles of 95 -C
for 30 s, 60 -C for 30 s, and 72 -C for 30 s. This PCR resulted in
the amplification of a 242 bp product. To visualize the products,
10 AL of each reaction was electrophoresed through an 8%
native TBE-polyacrylamide gel. After electrophoresis, the gel
was dried and exposed to autoradiography film. Unfortunately,
the nested PCR method combined with the [32P]TTP labeling
resulted in an occasional background band. It was for this reason
we analyzed for integration at both 24 and 48 hpi. Each mutant
was also assayed independently at least three times. The results
present the dominant phenotype observed.
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